Colombia vs Laos: The number of people with susceptibility test result for rifampicin
Colombia
3,134
in 2021
Laos
3,796
in 2021
Colombia rank
39th
Laos rank
36th
The number of people with susceptibility test result for rifampicin over time
- Colombia
- Laos
How they compare
Laos currently reports 3,796 against 3,134 in Colombia, a difference of 662.
That makes Laos's figure about 1.2 times Colombia's.
Across all 5 years both countries report, Laos has been ahead every year.
Colombia ranks 39th and Laos ranks 36th of 155 countries.
Laos has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Colombia | Laos | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,906 | 2,477 | 571.33 | Laos |
| 2020s | 2,255 | 3,803 | 1,548 | Laos |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Colombia or Laos?
- Laos, at 3,796 against 3,134 in Colombia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Colombia and Laos?
- 662, with Laos ahead.
- How many years of comparable data are there for Colombia and Laos?
- 5 years are reported by both, from 2017 to 2021.
- How do Colombia and Laos rank globally for the number of people with susceptibility test result for rifampicin?
- Colombia ranks 39th and Laos ranks 36th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.